TTI was awarded a contract to assess the cost-effectiveness of hypertension management strategies in persons with chronic kidney disease (CKD) for the Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP).
As part of this project, TTI will work with CDC/NCCDPHP to update, expand and validate current CKD cost effectiveness models, evaluate the cost effectiveness of blood pressure targets for CKD patients, and prepare a study report and manuscript for publication in a peer-reviewed journal.
“Winning this task order gives us the opportunity to help health care providers and payors make important decisions regarding chronic kidney disease management strategies,” said TTI’s President, Dr. April Zambelli-Weiner. “We’re looking forward to utilizing our team of senior epidemiologists and health economists to successfully carry out this critical work alongside national experts at CDC.”
Learn more about CDC’s Chronic Kidney Disease Initiative: